Skip to content

Dexamethasone Bioadhesive patch in the management of Oral Submucous Fibrosis - A non invasive approach

Comparative Evaluation of the Efficacy of Dexamethasone Bioadhesive patch and Dexamethasone Intralesional injection in Oral Submucous Fibrosis-A Clinico-Sonographic Study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024470
Enrollment
50
Registered
2020-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K135- Oral submucous fibrosis

Interventions

Intervention1: Dexamethasone bioadhesive (mucoadhesive) patch: Dexmethasone sodium phosphate loaded mucoadhesive patch (2mg/patch) to be pasted in bilateral buccal mucosa biweeky for 6 weeks - 12 patc

Sponsors

Dr Shilpa Shree K R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed cases of Oral Submucous fibrosis 2. Willing to participate in the study

Exclusion criteria

Exclusion criteria: 1.Previously treated and Stage IVb OSMF cases 2.Other fibrosis conditions like scleroderma, scarring, post radiation therapy 3.Immunocompromised patients and other systemic disorders like hypertension and diabetes mellitus 4.Not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Significant Decrease in the VAS score, Increase in the interincisal distance (mouth opening) and decrease in the submucosal thickness (measured via USG) in intervention group than comparator groupTimepoint: Baseline,3rd week, 6th week

Secondary

MeasureTime frame
Better patient compliance in study group than comparator group as mucoadhesive patch is non invasive, painless and sustained release formulationTimepoint: baseline, after 6th week

Countries

India

Contacts

Public ContactDr S Jayachandran MDS PhD FDSRCPSGlasg

Tamilnadu Government Dental College and Hospital

krshilpashree@gmail.com8056825595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026